Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis

In the aftermath of the COVID-19 pandemic, we are witnessing an unprecedented wave of post-infectious complications. Most prominently, millions of patients with Long-Covid complain about chronic fatigue and severe post-exertional malaise. Therapeutic apheresis has been suggested as an efficient trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Achleitner, Martin, Steenblock, Charlotte, Dänhardt, Juliane, Jarzebska, Natalia, Kardashi, Romina, Kanczkowski, Waldemar, Straube, Richard, Rodionov, Roman N., Bornstein, Nitzan, Tselmin, Sergey, Kaiser, Frank, Bucher, Ronald, Barbir, Mahmoud, Wong, Ma-Li, Voit-Bak, Karin, Licinio, Julio, Bornstein, Stefan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Immediate Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152027/
https://www.ncbi.nlm.nih.gov/pubmed/37131073
http://dx.doi.org/10.1038/s41380-023-02084-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152027/
https://www.ncbi.nlm.nih.gov/pubmed/37131073
http://dx.doi.org/10.1038/s41380-023-02084-1

Ejemplares similares